147 related articles for article (PubMed ID: 17602145)
1. Hemoglobin normalization studies.
Reddan D; Lappin DW; Tierney M; Szczech LA
Perit Dial Int; 2007; 27(4):395-9. PubMed ID: 17602145
[No Abstract] [Full Text] [Related]
2. [Current issues in erythropoietin therapy of renal anemia].
Zakar G
Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
[TBL] [Abstract][Full Text] [Related]
3. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
Nikolaev AIu; Klepikov PV; Lashutin SV
Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
[No Abstract] [Full Text] [Related]
4. The new label for erythropoiesis stimulating agents: the FDA'S sentence.
Fishbane S; Jhaveri KD
Semin Dial; 2012 May; 25(3):263-6. PubMed ID: 22515844
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients.
Mohammadpour AH; Nazemian F; Khaiat MH; Tafaghodi M; Salari P; Charkazi S; Naghibi M; Shamsara J
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):73-8. PubMed ID: 24434385
[TBL] [Abstract][Full Text] [Related]
6. Once-weekly epoetin-beta in renal anemia: the clinical evidence.
Albertazzi A
Contrib Nephrol; 2002; (137):408-11. PubMed ID: 12101986
[No Abstract] [Full Text] [Related]
7. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
8. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.
Barosi G; Merlo C; Palestra P; Liberato NL; Guarnone R; Di Dio F; Piazza V; Salvadeo A
Acta Haematol; 1993; 90(1):13-8. PubMed ID: 8237268
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
10. Finding a rational approach to ESA therapy--for payers and patients.
Messana A
Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
[No Abstract] [Full Text] [Related]
11. Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?
Covic A; Seica A; Gusbeth-Tatomir P; Goldsmith D
J Nephrol; 2008; 21(4):478-84. PubMed ID: 18651536
[TBL] [Abstract][Full Text] [Related]
12. Treating anemia with erythropoiesis-stimulating agents: effects on quality of life.
Moossavi S; Freedman BI
Arch Intern Med; 2009 Jun; 169(12):1100-1. PubMed ID: 19546408
[No Abstract] [Full Text] [Related]
13. Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients.
Schaefer RM; Schaefer L; Heidland A
Przegl Lek; 1992; 49(1-2):41-2. PubMed ID: 1455005
[No Abstract] [Full Text] [Related]
14. Anemia of chronic kidney disease: when normalcy becomes undesirable.
Demirjian SG; Nurko S
Cleve Clin J Med; 2008 May; 75(5):353-6. PubMed ID: 18556877
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin escape in five CAPD patients.
Williams P; Jones J
Nephron; 1996; 73(2):354. PubMed ID: 8773387
[No Abstract] [Full Text] [Related]
16. Parathyroidectomy and response to erythropoietin therapy in anaemic patients with chronic renal failure.
Mandolfo S; Malberti F; Farina M; Villa G; Scanziani R; Surian M; Imbasciati E
Nephrol Dial Transplant; 1998 Oct; 13(10):2708-9. PubMed ID: 9794600
[No Abstract] [Full Text] [Related]
17. [Hemoglobin target for chronic kidney disease patients?].
Drüeke TB
Nephrol Ther; 2007 Oct; 3(6):369-71. PubMed ID: 17919639
[No Abstract] [Full Text] [Related]
18. Biosimilar epoetin zeta in nephrology - a single-dialysis center experience.
Lonnemann G; Wrenger E
Clin Nephrol; 2011 Jan; 75(1):59-62. PubMed ID: 21176751
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin 1997: a brief update.
Gahl GM; Eckardt KU
Perit Dial Int; 1997; 17 Suppl 2():S84-90. PubMed ID: 9163805
[No Abstract] [Full Text] [Related]
20. Anemia therapy in ESRD: time to move on.
Folkert VW; Meyer TW; Hostetter TH
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1163-4. PubMed ID: 20538832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
